Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 339
Filter
1.
Bone Marrow Transplant ; 48(2): 257-64, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22750998

ABSTRACT

High incidences of human herpesvirus (HHV)-6 encephalitis have recently been reported from several Japanese SCT centers. To evaluate the effect of low-dose foscarnet (PFA) in preventing HHV-6 infection among recipients of unrelated BM or cord blood (CB), we examined consecutive cohorts without prophylaxis against HHV-6 (cohort 1, n=51) and with PFA prophylaxis (cohort 2, PFA 50 mg/kg/day for 10 days after engraftment, n=67). Plasma real-time PCR assay was performed weekly. High-level reactivation defined as HHV-6 DNA > or =10(4) copies/mL by day 70 was the primary endpoint. No significant reduction of high-level reactivation was seen in cohort 2 (19.4%) compared with cohort 1 (33.8%, P=0.095). A trend was identified toward fewer high-level HHV-6 reactivations in cohort 2 among recipients of unrelated BM (P=0.067), but no difference in incidence was observed among CB recipients (P=0.75). Breakthrough HHV-6 encephalitis occurred following PFA prophylaxis in three patients, and incidence of HHV-6 encephalitis did not differ between cohort 1 (9.9%) and cohort 2 (4.5%, P=0.24). In conclusion, 50 mg/kg/day of PFA does not effectively suppress HHV-6 reactivation and cannot prevent all cases of HHV-6 encephalitis. To effectively prevent HHV-6 encephalitis, alternative approaches based on the pathogenesis of HHV-6 encephalitis will probably be required.


Subject(s)
Antiviral Agents/therapeutic use , Encephalitis, Viral/drug therapy , Foscarnet/therapeutic use , Hematopoietic Stem Cell Transplantation/adverse effects , Hematopoietic Stem Cell Transplantation/methods , Herpesvirus 6, Human/physiology , Roseolovirus Infections/drug therapy , Adolescent , Adult , Aged , Cohort Studies , Encephalitis, Viral/etiology , Encephalitis, Viral/prevention & control , Encephalitis, Viral/virology , Humans , Incidence , Middle Aged , Roseolovirus Infections/etiology , Roseolovirus Infections/prevention & control , Roseolovirus Infections/virology , Transplantation, Homologous , Virus Activation/drug effects , Young Adult
2.
Bone Marrow Transplant ; 45(1): 129-36, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19465942

ABSTRACT

This study investigated factors associated with the development of human herpesvirus (HHV)-6 encephalitis. Among 111 enrolled subjects, 12 patients developed central nervous system (CNS) dysfunction. CNS dysfunction in four patients was found to have no association with HHV-6. The remaining eight patients displayed HHV-6 encephalitis (n=3), limbic encephalitis (HHV-6 DNA in cerebrospinal fluid was not examined; n=3) or CNS dysfunction because of an unidentified cause (n=2). Real-time PCR showed CNS dysfunction in the latter eight patients, which developed concomitant with the appearance of high plasma levels of HHV-6 DNA (> or =10(4) copies/ml). Overall, eight of the 24 patients with high-level HHV-6 DNA developed CNS dysfunction, whereas no patients developed CNS dysfunction potentially associated with HHV-6 infection if peak HHV-6 DNA was <10(4) copies/ml. We next analyzed plasma concentrations of IL-6, IL-10 and tumor necrosis factor-alpha among patients who displayed high-level plasma HHV-6 DNA and found elevated IL-6 concentrations preceding HHV-6 infection in patients who developed CNS dysfunction. (Mean+/-s.d.: 865.7+/-1036.3 pg/ml in patients with CNS dysfunction; 56.5+/-192.9 pg/ml in others; P=0.01). These results suggest that high-level HHV-6 load is necessary for the development of HHV-6 encephalitis, and systemic inflammatory conditions before HHV-6 infection form the preparatory conditions for progression to encephalopathy.


Subject(s)
Encephalitis, Viral/virology , Herpesvirus 6, Human , Interleukin-6/blood , Roseolovirus Infections/virology , Stem Cell Transplantation/adverse effects , Adolescent , Adult , Child , DNA, Viral/blood , Female , Herpesvirus 6, Human/genetics , Humans , Interleukin-10/blood , Male , Middle Aged , Tumor Necrosis Factor-alpha/blood , Viral Load
3.
Bone Marrow Transplant ; 41(3): 279-85, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18037945

ABSTRACT

Human herpesvirus 6 (HHV-6) causes life-threatening encephalopathy in recipients of allogeneic SCT, but no consensus has been reached regarding appropriate preventive methods. This study evaluated a plasma HHV-6 viral load-guided preemptive approach against HHV-6-associated encephalopathy. Plasma real-time PCR assay was performed once a week. Among 29 patients, 19 developed positive plasma HHV-6 DNA. Median maximum plasma HHV-6 DNA was 4593.5 copies/ml plasma (range, 150.0-127 891.0 copies/ml plasma). In one of eight events with low-level HHV-6 DNA (defined as <1000 copies/ml plasma) and four of seven events with mid-level HHV-6 DNA (1000-9999.5 copies/ml plasma), HHV-6 loads in plasma subsequently continued increasing. Ganciclovir was administered against six of nine patients with high-level HHV-6 DNA (> or =10,000 copies/ml plasma). High-level HHV-6 DNA resolved similarly in both groups with or without ganciclovir therapy. Among the nine patients with high-level HHV-6 DNA two developed encephalopathy. As encephalopathy developed before the detection of high-level HHV-6 DNA in plasma, these two patients had not received preemptive ganciclovir therapy. In conclusion, our preemptive approach against HHV-6-associated encephalopathy cannot prevent all cases of HHV-6 encephalopathy in SCT recipients due to the dynamic kinetics of plasma HHV-6 viral load.


Subject(s)
Encephalitis, Viral/prevention & control , Hematopoietic Stem Cell Transplantation/adverse effects , Herpesvirus 6, Human/drug effects , Roseolovirus Infections/prevention & control , Viral Load , Adolescent , Adult , Antiviral Agents/therapeutic use , Chemoprevention , DNA, Viral/blood , Encephalitis, Viral/virology , Female , Ganciclovir/therapeutic use , Herpesvirus 6, Human/pathogenicity , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Prospective Studies , Transplantation, Homologous/adverse effects , Treatment Outcome
4.
Bone Marrow Transplant ; 35(4): 403-10, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15592493

ABSTRACT

Real-time PCR has many advantages compared with antigenemia and qualitative PCR assays for detecting cytomegalovirus (CMV) infection in patients following SCT. However, the procedure used in each report was not standardized. This study compares the CMV load detected by real-time PCR assays amplifying distinct genomic regions. Real-time PCR assays based on US17, UL65, immediate early protein (IE) and glycoprotein B(gB) were selected and comparisons were made between each genomic region, and with antigenemia and nested PCR (IE region) in 18 SCT patients. The CMV load detected by real-time PCR using all combinations of primers targeting distinct genomic regions and by antigenemia assays correlated well. However, US17 and UL65-PCR could detect CMV earlier than gB-PCR, antigenemia and nested PCR assays. In longitudinal analysis, gB-PCR demonstrated a trend for showing a lower viral load in some patients than US17-, UL65- and IE-PCR. Moreover, the results suggest that a cutoff level of 500 copies/ml might be used to decide when to initiate treatment. We propose that monitoring should be carried out using real-time PCR assays targeting the US17 region and that a CMV load of 500 copies/ml could be used as a cutoff value for initiating treatment in patients following SCT, receiving immunoglobulin prophylaxis.


Subject(s)
Cytomegalovirus Infections/diagnosis , Cytomegalovirus/genetics , Genome, Viral , Hematopoietic Stem Cell Transplantation , Polymerase Chain Reaction , Virus Activation , Adult , Cytomegalovirus Infections/genetics , Female , Humans , Male , Middle Aged , Polymerase Chain Reaction/methods , Predictive Value of Tests , Sensitivity and Specificity , Virus Activation/genetics
5.
Rheumatology (Oxford) ; 42(8): 947-50, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12730504

ABSTRACT

OBJECTIVE: Regarding the interaction of Helicobacter pylori and non-steroidal anti-inflammatory drugs (NSAIDs), we cannot accept unanimous conclusions in inducing gastric ulcer. We therefore evaluated the role of Helicobacter pylori and NSAIDs in inducing gastric ulcer. METHODS: Dyspeptic patients receiving NSAIDs underwent endoscopic examination. Gastric ulcer formation and H. pylori status were investigated. Biopsy specimens from the antrum and lower body of the stomach were prepared for the rapid urease test and pathological evaluation. Anti-H. pylori antibody was measured by enzyme-linked immunosorbent assay. RESULTS: Two hundred and twenty-six patients receiving NSAIDs (220 chronic and six on-demand users) underwent gastrofibrescopic examination. There were 110 patients with gastric ulcer and 111 non-ulcer patients with gastritis. The remaining five patients had neither. NSAID users with gastric ulcer showed a low prevalence of H. pylori compared with those without them [55/110 (50.0%) vs 79/111 (71.2%), P < 0.01]. The same tendency was seen when patients receiving low-dose aspirin and those with rheumatoid arthritis were analysed separately [13/29 (44.8%) vs 50/62 (80.6%), P < 0.01, and 11/33 (33.3%) vs 16/26 (61.5%), P < 0.06 with Yates' correction, respectively]. CONCLUSION: Helicobacter pylori infection appeared to be a risk factor for developing gastritis, but we found no evidence that it increases gastric ulcer formation in NSAID users with dyspepsia.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Helicobacter Infections/complications , Helicobacter pylori , Stomach Ulcer/etiology , Aged , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antibodies, Bacterial/blood , Arthritis, Rheumatoid/complications , Arthritis, Rheumatoid/drug therapy , Chi-Square Distribution , Female , Gastritis/complications , Gastritis/microbiology , Helicobacter pylori/immunology , Humans , Male , Middle Aged , Stomach Ulcer/chemically induced , Stomach Ulcer/microbiology
6.
Bone Marrow Transplant ; 30(10): 699-701, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12420209

ABSTRACT

We report a 51-year-old male with adult T cell leukemia (ATL) who received a BMT from an HLA-identical unrelated donor. The ATL proved refractory to chemotherapy, and he underwent BMT conditioned with CY/TBI. Complications of encephalitis of unknown origin were successfully treated with steroid therapy and the patient has been in CR for 16 months after BMT. Human T cell leukemia virus type 1 proviral DNA loads were reduced to undetectable levels in PBMC sampled 12 months after BMT. This encouraging result suggests that BMT from an unrelated donor should be considered for ATL even if the disease is refractory to chemotherapy.


Subject(s)
Bone Marrow Transplantation/methods , Leukemia-Lymphoma, Adult T-Cell/therapy , Bone Marrow Transplantation/adverse effects , Bone Marrow Transplantation/immunology , Disease-Free Survival , Encephalitis/drug therapy , Encephalitis/etiology , Humans , Leukemia-Lymphoma, Adult T-Cell/complications , Male , Middle Aged , Remission Induction , Tissue Donors , Transplantation, Homologous , Transplantation, Isogeneic , Treatment Outcome
7.
Article in English | MEDLINE | ID: mdl-11563126

ABSTRACT

An effective approach to promote sequence-specific RNA cleavage by an antisense 2'-O-methyloligonucleotide with a terpyridine.Cu(II) complex attached at the 5'-end was developed. We have synthesized a Cu(II) complex 3'-conjugate, which when used in a tandem fashion, greatly enhanced the RNA cleavage efficiency.


Subject(s)
Copper/chemistry , Oligonucleotides, Antisense/chemistry , Organometallic Compounds/chemistry , Pyridines/chemistry , RNA/chemistry , Copper/pharmacology , Oligonucleotides, Antisense/chemical synthesis , Oligonucleotides, Antisense/pharmacology , Organometallic Compounds/chemical synthesis , Organometallic Compounds/pharmacology , Pyridines/chemical synthesis , Pyridines/pharmacology , RNA/drug effects , RNA/metabolism
8.
Jpn J Pharmacol ; 86(1): 97-105, 2001 May.
Article in English | MEDLINE | ID: mdl-11430478

ABSTRACT

We investigated itch-associated responses (scratching) to mosquito bites and the role of histamine and mast cells in mosquito-induced itching in mice. Although the first bites of mosquito Aedes albopictus did not increase scratching, repeated bites increased scratching. The response was not diminished even after an interval of 2 months. Similarly, repeated intradermal (i.d.) injections of salivary gland extract (SGE) from Aedes albopictus increased scratching after SGE injection itself and mosquito bites. The scratching peaked within 10 min and almost subsided by 60 min. The opioid antagonist naloxone (1 mg/kg, s.c.) inhibited scratching following SGE injection. Although the non-sedative H1-histamine-receptor antagonist terfenadine (30 mg/kg, p.o.) significantly suppressed scratching induced by histamine (100 nmol/site, i.d.) in either naive or mosquito-sensitized mice, it did not affect mosquito-induced scratching in mosquito-sensitized mice. Repeated injections of SGE increased scratching in mast cell-deficient (WBB6F1-W/Wv) mice as well as in normal (WBB6F1-+/+) littermates. Repeated exposure to mosquito bites roughly doubled serum concentrations of total IgE and IgG1, but not IgG2a. Repeated injections of SGE markedly increased plasma extravasation induced by mosquito bites and such an increase was almost completely suppressed by terfenadine (30 mg/kg, p.o.). The results show the presence of histamine-mediated and histamine-independent mechanisms in cutaneous itching and suggest that histamine probably released from mast cells does not play an important role in itching in immediate allergic reaction. Our murine model of mosquito itching may be useful for studying the mechanisms of immediate allergic itching.


Subject(s)
Aedes , Histamine/physiology , Hypersensitivity/pathology , Insect Bites and Stings/pathology , Mast Cells/pathology , Pruritus/pathology , Animals , Capillary Permeability/drug effects , Coloring Agents , Hypersensitivity/immunology , Immunoglobulin E/blood , Immunoglobulin G/blood , Insect Bites and Stings/immunology , Male , Mast Cells/immunology , Mice , Mice, Inbred ICR , Salivary Glands/chemistry , Salivary Glands/immunology , Tolonium Chloride
9.
Rinsho Ketsueki ; 41(7): 596-600, 2000 Jul.
Article in Japanese | MEDLINE | ID: mdl-11020984

ABSTRACT

In Saiki City, Oita, Japan, erythema infectiosum in children has been prevalent from June, 1999 to the time of writing (January, 2000). We present three adult cases of parvovirus B19-associated leukocytopenia and thrombocytopenia that developed during this epidemic. Between June and November, 1999, a 32-year-old woman, a 38-year-old woman, and a 63-year-old man were referred to our hospital for treatment of leukocytopenia and thrombocytopenia. All complained of common cold-like symptoms. Their WBC counts (percentage of neutrophils) were 1,000/microliter (70%), 1,900/microliter (40%) and 1,680/microliter (40%), their hemoglobin levels 9.4 g/dl, 9.8 g/dl and 14.9 g/dl, and their platelet counts 10.8 x 10(4)/microliter, 6.9 x 10(4)/microliter and 4.5 x 10(4)/microliter, respectively. The diagnosis of parvovirus B19 infection was documented by the presence of B19-specific IgM antibodies or serum positivity for viral DNA. In two cases, the leukocytopenia and thrombocytopenia resolved gradually. In the other case, leukocytopenia, thrombocytopenia and B19 infection persisted for more than two months. These cases suggest that parvovirus B19 may be a common cause of leukocytopenia and thrombocytopenia even in adult patients without hematological disorders (erythropoietic stress), and that testing for parvovirus infection is justified in such patients, even if anemia is slight, especially when erythema infectiosum is prevalent.


Subject(s)
Leukopenia/etiology , Parvoviridae Infections/complications , Parvovirus B19, Human , Thrombocytopenia/etiology , Adult , Female , Humans , Male , Middle Aged
10.
Neurosci Lett ; 290(2): 154-6, 2000 Aug 25.
Article in English | MEDLINE | ID: mdl-10936700

ABSTRACT

Alpha-2 macroglobulin (A2M) is a serum pan-protease inhibitor that is related with the pathogenesis of Alzheimer's disease (AD) through its ability to mediate amyloid beta degradation. Recently, it has been reported that the I1000V polymorphism in A2M gene might increase the risk of AD. In the present study, we investigated this mutation in 95 healthy controls and in 111 sporadic AD cases by polymerase chain reaction-restriction fragment length polymorphism method in order to study this hypothesis in the Japanese AD population. Allelic frequencies with the I1000V polymorphism in the gene were 7.4 and 6.8% in the control and AD groups, respectively. Our results failed to demonstrate an association between this polymorphism and Japanese sporadic AD, and the A2M I1000V mutation does not seem to be a risk factor per se for sporadic AD.


Subject(s)
Alzheimer Disease/genetics , Alzheimer Disease/physiopathology , Polymorphism, Genetic/genetics , alpha-Macroglobulins/genetics , Aged , Humans , Japan , Risk Factors
11.
J Mol Biol ; 299(3): 711-23, 2000 Jun 09.
Article in English | MEDLINE | ID: mdl-10835279

ABSTRACT

DNA photoproducts with (6-4) pyrimidine-pyrimidone adducts formed by ultraviolet radiation are implicated in mutagenesis and cancer, particularly skin cancer. The crystal structure of the Fab fragment of the murine 64M-2 antibody specific to DNA T(6-4)T photoproducts is determined as a complex with dT(6-4)T, a (6-4) pyrimidine-pyrimidone photodimer of dTpT, at 2.4 A resolution to a crystallographic R-factor of 0.199 and an R(free) value of 0.279. The 64M-2 Fab molecule is in an extended arrangement with an elbow angle of 174 degrees, and its five complementarity-determining regions, except L2, are involved in the ligand binding. The bound dT(6-4)T ligand adopting a ring structure with (6-4) linked 5' thymine-3' pyrimidone bases is fully accommodated in an antigen-binding pocket of about 15 Ax10 A. The 5'-thymine and 3'-pyrimidone bases are in half-chair and planar conformations, respectively, and are nearly perpendicular to each other. The 5'-thymine base is hydrogen-bonded to Arg95H and Ser96H, and is in van der Waals contact with Tyr100iH. The 3'-pyrimidone base is hydrogen-bonded to His35H, and is in contact with Trp33H. Three water molecules are located at the interface between the bases and the Fab residues. Hydrogen bonds involving these water molecules also contribute to Fab recognition of the dT(6-4)T bases. The sugar-phosphate backbone connecting the bases is surrounded by residues His27dL, Tyr32L, Ser92L, Trp33H, and Ser58H, but is not hydrogen-bonded to these residues.


Subject(s)
Antibodies, Antinuclear/chemistry , DNA/chemistry , DNA/immunology , Immunoglobulin Fab Fragments/chemistry , Nucleic Acid Conformation/radiation effects , Ultraviolet Rays , Animals , Antibodies, Antinuclear/immunology , Antibody Specificity , Binding Sites, Antibody , Cattle , Crystallography, X-Ray , DNA/genetics , DNA/radiation effects , DNA Damage/genetics , DNA Damage/immunology , DNA Damage/radiation effects , DNA, Single-Stranded/chemistry , DNA, Single-Stranded/genetics , DNA, Single-Stranded/immunology , DNA, Single-Stranded/radiation effects , Epitopes/chemistry , Epitopes/genetics , Epitopes/immunology , Epitopes/radiation effects , Hydrogen Bonding , Immunoglobulin Fab Fragments/immunology , Immunoglobulin Variable Region/chemistry , Immunoglobulin Variable Region/immunology , Mice , Mice, Inbred BALB C , Models, Molecular , Molecular Sequence Data , Nucleotides/chemistry , Nucleotides/genetics , Nucleotides/immunology , Protein Conformation , Pyrimidine Dimers/chemistry , Pyrimidine Dimers/genetics , Pyrimidine Dimers/immunology , Pyrimidine Dimers/radiation effects , Static Electricity , Water/metabolism
12.
J Mol Biol ; 299(5): 1231-43, 2000 Jun 23.
Article in English | MEDLINE | ID: mdl-10873448

ABSTRACT

A hairpin loop and an oligonucleotide bound to the loop form one-half of the pseudoknot structure. We have designed an allosteric hammerhead ribozyme, which is activated by the introduction of this motif by using a short complementary oligonucleotide as a cofactor. Stem II of the hammerhead ribozyme was substituted with a non-self-complementary loop sequence (loop II) to abolish the cleavage activity. The new ribozyme had almost no cleavage activity of the target RNA. However, it exhibited the cleavage activity in the presence of a cofactor oligoribonucleotide, which is complementary to loop II of the ribozyme. The activity is assumed to be derived from the formation of a pseudo-stem structure between the cofactor oligonucleotide and loop II. The structure including the loop may be similar to the pseudo-half-knot structure. The activation efficiencies of the cofactor oligonucleotides were decreased as the lengths of the oligonucleotides increased, and the ribozyme with a longer loop II was more active than that with a short loop II. Oligoribonucleotides with 3'-dangling purine bases served as efficient cofactors of the ribozyme, and a 2'-O-methyloligonucleotide enhanced the cleavage activity of the ribozyme most efficiently, by as much as about 750-fold as compared with that in the absence of the oligonucleotide. Cofactor oligonucleotides with a cytidine base at the 3'-end also activated a ribozyme with the G10.1.G11.1 mutation, which eliminates the cleavage activity in the wild-type. The binding sites of the oligonucleotide were identified by photo-crosslinking experiments and were found to be the predicted sites in the loop. This is the first report of a design aimed at positively controlling the activity of ribozymes by employing a structural motif. This method can be applied to control the activities of other functional RNAs with hairpin loops.


Subject(s)
Coenzymes/pharmacology , Nucleic Acid Conformation/drug effects , Oligoribonucleotides/pharmacology , RNA, Catalytic/chemistry , RNA, Catalytic/metabolism , Allosteric Regulation/drug effects , Base Pairing/genetics , Base Sequence , Binding Sites , Catalysis/drug effects , Coenzymes/chemistry , Coenzymes/genetics , Coenzymes/metabolism , Enzyme Activation/drug effects , Kinetics , Mutation/genetics , Oligoribonucleotides/chemistry , Oligoribonucleotides/genetics , Oligoribonucleotides/metabolism , Photochemistry , RNA, Catalytic/genetics , Substrate Specificity
13.
J Biochem ; 127(4): 531-6, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10739942

ABSTRACT

Functional structures of hairpin ribozymes have been investigated by constructing various chemically modified molecules. Domain-exchange and linker insertion experiments were performed to find active conformations of the RNA enzyme showing cleavage activity. Our experiments and other evidence suggest that the active structure has a bent conformation, and that domain-interactions are essential for the cleavage activity.


Subject(s)
Nucleic Acid Conformation , RNA, Catalytic/chemistry , RNA, Viral/chemistry , Nepovirus/genetics , RNA/chemistry , RNA/metabolism , RNA, Catalytic/metabolism , RNA, Viral/metabolism , Substrate Specificity , Transcription, Genetic
14.
Nucleic Acids Res ; 28(24): 4956-63, 2000 Dec 15.
Article in English | MEDLINE | ID: mdl-11121487

ABSTRACT

A nuclear recessive mutant in Saccharomyces cerevisiae, mhr1-1, is defective in mitochondrial genetic recombination at 30 degrees C and shows extensive vegetative petite induction by UV irradiation at 30 degrees C or when cultivated at a higher temperature (37 degrees C). It has been postulated that mitochondrial DNA (mtDNA) is oxidatively damaged by by-products of oxidative respiration. Since genetic recombination plays a critical role in DNA repair in various organisms, we tested the possibility that MHR1 plays a role in the repair of oxidatively damaged mtDNA using an enzyme assay. mtDNA isolated from cells grown under standard (aerobic) conditions contained a much higher level of DNA lesions compared with mtDNA isolated from anaerobically grown cells. Soon after a temperature shift from 30 to 37 degrees C the number of mtDNA lesions increased 2-fold in mhr1-1 mutant cells but not in MHR1 cells. Malonic acid, which decreased the oxidative stress in mitochondria, partially suppressed both petite induction and the temperature-induced increase in the amount of mtDNA damage in mhr1-1 cells at 37 degrees C. Thus, functional mitochondria require active MHR1, which keeps the extent of spontaneous oxidative damage in mtDNA within a tolerable level. These observations are consistent with MHR1 having a possible role in mtDNA repair.


Subject(s)
DNA Damage/genetics , DNA Repair/genetics , DNA, Mitochondrial/genetics , Fungal Proteins/metabolism , Nuclear Proteins/metabolism , Recombination, Genetic/genetics , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/genetics , Transcription Factors , Aerobiosis , Alloxan/pharmacology , Citric Acid Cycle/drug effects , DNA Damage/radiation effects , DNA Repair/drug effects , DNA, Fungal/genetics , DNA, Fungal/metabolism , Electron Transport Complex IV/antagonists & inhibitors , Electron Transport Complex IV/metabolism , Fungal Proteins/genetics , Genes, Fungal/genetics , Malonates/pharmacology , Mitochondria/drug effects , Mitochondria/genetics , Mitochondria/metabolism , Mitochondria/radiation effects , Molecular Sequence Data , Mutation/genetics , Mutation/radiation effects , Oxidants/pharmacology , Oxidative Stress/drug effects , Reactive Oxygen Species/metabolism , Reproducibility of Results , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae/radiation effects , Sodium Azide/pharmacology , Temperature , Ultraviolet Rays
15.
Nucleic Acids Res ; 28(4): 944-51, 2000 Feb 15.
Article in English | MEDLINE | ID: mdl-10648787

ABSTRACT

Monoclonal antibodies specific for the cyclobutane pyrimidine dimer (CPD) are widely used for detection and quantification of DNA photolesions. However, the mechanisms of antigen binding by anti-CPD antibodies are little understood. Here we report NMR analyses of antigen recognition by TDM-2, which is a mouse monoclonal antibody specific for the cis - syn -cyclobutane thymine dimer (T[ c, s ]T). (31)P NMR and surface plasmon resonance data indicated that the epitope recognized by TDM-2 comprises hexadeoxynucleotides centered on the CPD. Chemical shift perturbations observed for TDM-2 Fab upon binding to d(T[ c, s ]T) and d(TAT[ c, s ]TAT) were examined in order to identify the binding sites for these antigen analogs. It was revealed that d(T[ c, s ]T) binds to the central part of the antibody-combining site, while the CPD-flanking nucleotides bind to the positively charged area of the V(H)domain via electrostatic interactions. By applying a novel NMR method utilizing a pair of spin-labeled DNA analogs, the orientation of DNA with respect to the antigen-binding site was determined: CPD-containing oligonucleotides bind to TDM-2 in a crooked form, draping the 3'-side of the nucleotides onto the H1 and H3 segments, with the 5'-side on the H2 and L3 segments. These data provide valuable information for antibody engineering of TDM-2.


Subject(s)
Antibodies, Monoclonal/immunology , DNA/metabolism , Immunoglobulin Fab Fragments/metabolism , Pyrimidine Dimers/immunology , Animals , Computer Simulation , Magnetic Resonance Spectroscopy , Mice , Models, Molecular , Phosphorus Isotopes , Protein Binding , Spin Labels
16.
Bone Marrow Transplant ; 26(11): 1235-7, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11149739

ABSTRACT

We report here the first case report of bone marrow transplantation (BMT)-related transmission of human T lymphotropic virus type-I (HTLV-I). Antibodies against HTLV-I-associated antigens (anti-HTLV-I) were detected in the serum from the BMT recipient 12 days post BMT. IgG against gag core proteins (anti-p19 and anti-p24) appeared earlier than IgM against gag and env proteins (anti-p19, anti-p24 and anti-gp46) during seroconversion. The data presented here differs from blood transfusion-related seroconversion. This phenomenon may be due to the engraftment of anti-HTLV-I producing cells from the donor.


Subject(s)
Bone Marrow Transplantation/adverse effects , HTLV-I Infections/transmission , Human T-lymphotropic virus 1 , Adolescent , Anemia, Aplastic/therapy , Carrier State/virology , HTLV-I Antibodies/blood , HTLV-I Infections/immunology , Humans , Living Donors , Male
17.
Nucleic Acids Symp Ser ; (44): 279-80, 2000.
Article in English | MEDLINE | ID: mdl-12903377

ABSTRACT

In an approach toward artificial ribonucleases, novel RNA cleaving systems were constructed that contained two terpyridine.Cu(II) residues. The first antisense system used tandem Cu(II) complex--2'-O-methyloligonucleotide 5'- and 3'-conjugates to cleave an RNA substrate. The second system, which will be described in a future paper, contained two contiguous Cu(II) complex residues at an internal site of a 2'-O-methyloligonucleotide. We found that the first system rapidly cleaved RNA with high site-specificity. Based on these results, we expect the second system to also show efficient RNA cleavage.


Subject(s)
Oligoribonucleotides, Antisense/chemistry , Oligoribonucleotides, Antisense/metabolism , Pyridines/chemistry , RNA/chemistry , RNA/metabolism , Base Sequence , Binding Sites , Copper/chemistry , Drug Design , In Vitro Techniques , Molecular Structure , Oligoribonucleotides, Antisense/genetics , RNA/genetics , Ribonucleases/chemistry , Ribonucleases/metabolism
18.
Protein Eng ; 12(10): 879-84, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10556249

ABSTRACT

The importance of Trp H33 in antibody recognition of DNA containing a central pyrimidine (6-4) pyrimidone photoproduct was investigated. This residue was replaced by Tyr, Phe and Ala and the binding abilities of these mutants were determined by surface plasmon resonance and fluorescence spectroscopy. Conservative substitution of Trp H33 by Tyr or Phe resulted in moderate losses of binding affinity; however, replacement by Ala had a significantly larger impact. The fluorescence properties of DNA containing a (6-4) photoproduct were strongly affected by the identity of the H33 residue. DNA binding by both the wild-type and the W-H33-Y mutant was accompanied by a small degree of fluorescence quenching; by contrast, binding by the W-H33-F and W-H33-A mutants produced large fluorescence increases. Taken together, these variations in binding and fluorescence properties with the identity of the H33 residue are consistent with a role in photoproduct recognition by Trp H33 in the high-affinity antibody 64M5.


Subject(s)
Antibody Affinity/genetics , Antibody Specificity/genetics , Immunoglobulin Variable Region/metabolism , Pyrimidine Dimers/immunology , Pyrimidine Dimers/metabolism , Tryptophan/metabolism , Alanine/genetics , Alanine/metabolism , Amino Acid Substitution/genetics , Chromatography, Affinity , DNA/metabolism , Immunoglobulin Fragments/genetics , Immunoglobulin Fragments/isolation & purification , Immunoglobulin Fragments/metabolism , Immunoglobulin Variable Region/genetics , Mutagenesis, Site-Directed , Phenylalanine/genetics , Phenylalanine/metabolism , Protein Binding , Protein Folding , Spectrometry, Fluorescence , Surface Plasmon Resonance , Tryptophan/genetics , Tryptophan/physiology , Tyrosine/genetics , Tyrosine/metabolism
19.
Am J Hematol ; 62(2): 120-1, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10577282

ABSTRACT

We measured N-formyl-methionyl-leucyl-phenylalanine-induced reactive oxygen species production by neutrophils from three patients with acute promyelocytic leukemia during treatment with all-trans retinoic acid using a luminol-enhanced chemiluminescence assay. The maximum level of reactive oxygen species production during all-trans retinoic acid treatment was 58.8 +/- 2.3 x 10(4) (mean +/- SEM) counted photons per seconds (cps), which was significantly higher (p<0.0001) than that of neutrophils from health volunteers (13.3 +/- 2.3 x 10(4) cps).


Subject(s)
Antineoplastic Agents/therapeutic use , Leukemia, Promyelocytic, Acute/blood , Leukemia, Promyelocytic, Acute/drug therapy , Neutrophils/physiology , Reactive Oxygen Species/metabolism , Tretinoin/therapeutic use , Humans , Luminescent Measurements , Luminol , Neutrophils/drug effects , Reference Values , Time Factors
20.
Yakugaku Zasshi ; 119(9): 625-36, 1999 Sep.
Article in Japanese | MEDLINE | ID: mdl-10511816

ABSTRACT

Syntheses of nucleic acids are of importance not only in the natural product chemistry but also in the molecular recognition study in biology. This review describes syntheses of RNA and DNA, which were found to be related each other. Deoxyinosine probes were developed for cloning genes with degenerated codons. Synthetic genes for c-Ha-ras and T4 endonuclease V provided new approaches in recognition of nucleic acids by proteins. Antibodies specific for photo-damaged pyrimidines in DNA have been studied by cloning and mutating their genes.


Subject(s)
DNA/chemical synthesis , RNA/chemical synthesis , Viral Proteins , DNA Damage , DNA Probes , DNA Repair , Deoxyribonuclease (Pyrimidine Dimer) , Endodeoxyribonucleases , Gene Silencing , Genes, ras/genetics , Inosine/analogs & derivatives , Mutation , RNA, Catalytic
SELECTION OF CITATIONS
SEARCH DETAIL
...